Orion Infusion

Orion Infusion

Orion Infusion to invest Tk20cr to expand IV fluids production

Orion Infusion to invest Tk20cr to expand IV fluids production

The board of directors has also declared a 20% cash dividend for general shareholders for FY25.

Beacon Pharma, Eastern Bank, Orion Infusion lift DSEX despite most stocks falling

Beacon Pharma, Eastern Bank, Orion Infusion lift DSEX despite most stocks falling

Orion Infusion: Un-Audited Half Yearly (Q2) Financial Statements

Orion Infusion: Un-Audited Half Yearly (Q2) Financial Statements

Orion Infusion: Price Sensitive Information

Orion Infusion: Price Sensitive Information

Orion Infusion: Un-audited half yearly (Q2) financial statements

Orion Infusion: Un-audited half yearly (Q2) financial statements

Orion Infusion Ltd: Unaudited 1st quarterly financial statement

Orion Infusion Ltd: Unaudited 1st quarterly financial statement

2 Orion Group firms post earnings growth in Q3

2 Orion Group firms post earnings growth in Q3

Orion Infusion: Un-audited Third Quarterly (Q3) Financial Statements

Orion Infusion: Un-audited Third Quarterly (Q3) Financial Statements

37th AGM of Orion Infusion ltd held

37th AGM of Orion Infusion ltd held

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements - DSE

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements - DSE

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements - CSE

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements - CSE

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements - BSEC

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements - BSEC

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements

Orion Infusion: Un-Audited Third Quarterly (Q3) Financial Statements